ADO 3.85% 2.7¢ anteotech ltd

the million dollar question..., page-26

  1. 10,789 Posts.
    lightbulb Created with Sketch. 248
    Perhaps you could point me to where there is clear evidence that any commercial royalties have been received under the eBioscience contract? I might have missed that.

    But I believe that it is correct to say that any royalty revenues, if any, that have been received under the eBioscience (or any other contract) are not clear (again please correct me if I am wrong) and all revenues are certainly light versus current market cap, even light versus CEO salary. My impression is that the revenues could all be non-royalty revenues.

    The market is anticipating quite a lot here, which is all fine and good.
    anticipation is a wonderful thing

    and jimvho this is looking very much like a pump and dump based on that anticipation

 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.001(3.85%)
Mkt cap ! $67.22M
Open High Low Value Volume
2.7¢ 2.7¢ 2.6¢ $12.09K 448.4K

Buyers (Bids)

No. Vol. Price($)
7 648153 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 35520 1
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.